Associations Between Altered Auditory EEG Markers and Clinical Impairments in Fragile X Syndrome

CONCLUSIONS: These findings confirm that abnormalities of the N1 and P2 components are robust biomarkers of altered sensory processing in FXS and suggest that these alterations may present a dose-response relation to clinical impairments in FXS.

via https://pubmed.ncbi.nlm.nih.gov/41051455/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20251007010804&v=2.18.0.post9+e462414